Literature DB >> 24387877

Community-acquired pneumonia among smokers.

Jordi Almirall1, José Blanquer2, Salvador Bello3.   

Abstract

Recent studies have left absolutely no doubt that tobacco increases susceptibility to bacterial lung infection, even in passive smokers. This relationship also shows a dose-response effect, since the risk reduces spectacularly 10 years after giving up smoking, returning to the level of non-smokers. Streptococcus pneumoniae is the causative microorganism responsible for community-acquired pneumonia (CAP) most frequently associated with smoking, particularly in invasive pneumococcal disease and septic shock. It is not clear how it acts on the progress of pneumonia, but there is evidence to suggest that the prognosis for pneumococcal pneumonia is worse. In CAP caused by Legionella pneumophila, it has also been observed that smoking is the most important risk factor, with the risk rising 121% for each pack of cigarettes smoked a day. Tobacco use may also favor diseases that are also known risk factors for CAP, such as periodontal disease and upper respiratory viral infections. By way of prevention, while giving up smoking should always be proposed, the use of the pneumococcal vaccine is also recommended, regardless of the presence of other comorbidities.
Copyright © 2013 SEPAR. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Community-acquired pneumonia; Factores de riesgo; Neumonía adquirida en la comunidad; Prevención; Prevention; Risk factors; Smoking; Tabaquismo

Mesh:

Substances:

Year:  2013        PMID: 24387877     DOI: 10.1016/j.arbres.2013.11.016

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  13 in total

1.  IFN-γ induction by neutrophil-derived IL-17A homodimer augments pulmonary antibacterial defense.

Authors:  S Cai; S Batra; I Langohr; Y Iwakura; S Jeyaseelan
Journal:  Mucosal Immunol       Date:  2015-09-09       Impact factor: 7.313

2.  Risk of community-acquired pneumonia in older adults with sarcopenia of a hospital from Callao, Peru 2010-2015.

Authors:  Sofia Altuna-Venegas; Raul Aliaga-Vega; Jorge L Maguiña; Jose F Parodi; Fernando M Runzer-Colmenares
Journal:  Arch Gerontol Geriatr       Date:  2019-01-29       Impact factor: 3.250

3.  Respiratory infections and pneumonia: potential benefits of switching from smoking to vaping.

Authors:  Davide Campagna; Maria Domenica Amaradio; Mark F Sands; Riccardo Polosa
Journal:  Pneumonia (Nathan)       Date:  2016-04-12

Review 4.  The Implication of Oxidative Stress and AMPK-Nrf2 Antioxidative Signaling in Pneumonia Pathogenesis.

Authors:  Weitong Xu; Tingting Zhao; Hengyi Xiao
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-17       Impact factor: 5.555

5.  Do outpatient statins and ACEIs/ARBs have synergistic effects in reducing the risk of pneumonia? A population-based case-control study.

Authors:  Jiunn-Horng Kang; Li-Ting Kao; Herng-Ching Lin; Ta-Jung Wang; Tsung-Yeh Yang
Journal:  PLoS One       Date:  2018-06-28       Impact factor: 3.240

6.  The role of Endocan as a Prognostic Biomarker in community-acquired pneumonia.

Authors:  Senay Gunaydin; Mehmet Kucuk; Ulug Mutlu Gunaydin
Journal:  Pak J Med Sci       Date:  2019 Jan-Feb       Impact factor: 1.088

7.  Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts.

Authors:  Vivian M Raeven; Simone M C Spoorenberg; Wim G Boersma; Ewoudt M W van de Garde; Suzanne C Cannegieter; G P Paul Voorn; Willem Jan W Bos; Jim E van Steenbergen
Journal:  BMC Infect Dis       Date:  2016-06-17       Impact factor: 3.090

8.  Risk of community-acquired pneumonia in chronic obstructive pulmonary disease stratified by smoking status: a population-based cohort study in the United Kingdom.

Authors:  Dionne Cw Braeken; Gernot Gu Rohde; Frits Me Franssen; Johanna Hm Driessen; Tjeerd P van Staa; Patrick C Souverein; Emiel Fm Wouters; Frank de Vries
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-08-14

9.  COVID-19: counter-intuitive data on smoking prevalence and therapeutic implications for nicotine.

Authors:  Riccardo Polosa; Grazia Caci
Journal:  Intern Emerg Med       Date:  2020-05-19       Impact factor: 5.472

10.  Comorbidities impact on the prognosis of severe acute community-acquired pneumonia.

Authors:  Ana Vidal; Lurdes Santos
Journal:  Porto Biomed J       Date:  2017-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.